DBD logo

DBD

Diebold Nixdorf, IncorporatedNYSETechnology
$77.32-0.44%ClosedMarket Cap: $2.77B

As of 2026-04-06

Valuation

P/E (TTM)

29.32

PEG

0.04

P/B

2.55

P/S

0.73

EV/EBITDA

9.34

DCF Value

$145.58

FCF Yield

8.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

25.9%

Operating Margin

7.5%

Net Margin

2.5%

ROE

8.8%

ROA

3.9%

ROIC

9.1%

Income Statement
PeriodRevenueGross MarginOperating IncomeNet IncomeEPSDividend
Q4 2025$1.10B27.1%$127.6M$49.6M$1.37
FY 2025$3.81B25.3%$242.0M$94.6M$2.54
Q3 2025$945.2M26.2%$73.8M$41.1M$1.11
Q2 2025$915.2M25.6%$56.2M$12.2M$0.33
Q1 2025$841.1M24.1%$29.6M$-8.3M$-0.22
Q4 2024$988.9M23.9%$41.2M$5.6M$0.15
FY 2024$3.75B24.5%$182.1M$-16.5M$-0.44
Q3 2024$927.1M25.5%$46.4M$-22.4M$-0.60
Q2 2024$939.7M25.9%$70.7M$14.9M$0.40
Q1 2024$895.4M23.3%$23.8M$-14.6M$-0.39
Q4 2023$1.04B21.7%$55.5M$22.3M$0.59
FY 2023$3.76B23.3%$86.9M$1.38B$21.38